Therefore, taken together our findings highlight Rab4 and the axonal endosomal pathway as a potential target that can be explored for early therapeutics prior to the onset of neuronal degeneration and behavioral defects observed in HD. The gene discussed is RAB4A; the disease is Huntington disease.